Limited Value of the Multi‐biomarker Disease Activity Assay Compared to the Routine Assessment of Patient Index Data 3 (rapid3) Score in the Prognosis of Important Clinical Outcomes in Rheumatoid Arthritis: Comment on the Article by Fleischmann et al and Accompanying Editorial by Davis

DOI: 10.1002/art.40022

,

Issn Print: 2326-5191

Publication Date: 2017/04/01

Limited Value of the Multi‐Biomarker Disease Activity Assay Compared to the Routine Assessment of Patient Index Data 3 (RAPID3) Score in the Prognosis of Important Clinical Outcomes in Rheumatoid Arthritis: Comment on the Article by Fleischmann et al and Accompanying Editorial by Davis

Theodore Pincus; Joel A. Block; Yusuf Yazici; Martin J. Bergman; Tuulikki Sokka

Author Information: Rush University Medical Center


		Checking for direct PDF access through Ovid

View on Journal Site

Abstract unavailable for this article.


		Loading Related Articles